KPCB XVI Associates
Latest statistics and disclosures from KPCB XVI Associates's latest quarterly 13F-HR filing:
- Top 5 stock holdings are DM, Aeye, VERA, and represent 100.00% of KPCB XVI Associates's stock portfolio.
- Added to shares of these 1 stock: Aeye (+$76M).
- Started 1 new stock position in Aeye.
- KPCB XVI Associates was a net buyer of stock by $76M.
- KPCB XVI Associates has $225M in assets under management (AUM), dropping by 3.38%.
- Central Index Key (CIK): 0001611734
Tip: Access up to 7 years of quarterly data
Positions held by KPCB XVI Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for KPCB XVI Associates
KPCB XVI Associates holds 3 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Desktop Metal Class A Common Stock (DM) | 55.9 | $125M | 18M | 7.17 |
|
|
| AEye Class A Common Stock | 33.8 | $76M | NEW | 14M | 5.47 |
|
| Vera Therapeutics Class A Common Stock (VERA) | 10.4 | $23M | 1.3M | 17.35 |
|
Past Filings by KPCB XVI Associates
SEC 13F filings are viewable for KPCB XVI Associates going back to 2019
- KPCB XVI Associates 2021 Q3 filed Oct. 25, 2021
- KPCB XVI Associates 2021 Q2 filed July 28, 2021
- KPCB XVI Associates 2021 Q1 filed May 13, 2021
- KPCB XVI Associates 2020 Q4 filed Feb. 16, 2021
- KPCB XVI Associates 2020 Q3 filed Oct. 20, 2020
- KPCB XVI Associates 2020 Q2 filed Aug. 3, 2020
- KPCB XVI Associates 2020 Q1 filed April 10, 2020
- KPCB XVI Associates 2019 Q4 filed Feb. 13, 2020